New Risk • 16h
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.1% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Board Change • May 20
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Mike Humphrey was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Mar 24
Elementis plc to Report Q1, 2026 Results on Apr 29, 2026 Elementis plc announced that they will report Q1, 2026 results on Apr 29, 2026 Announcement • Mar 19
Elementis PLC Announces Board Changes Elementis PLC announced the appointment of Trudy Schoolenberg as Non-Executive Chair with effect from the end of the Annual General Meeting on April 29, 2026. Trudy will succeed John O'Higgins who announced in October 2026 that he would not stand for re-election. Trudy has served as Non-Executive Senior Independent Director of Elementis since April 2022. She has around 35 years' experience in the chemicals, engineering and high-performance product sectors, including ten years as a Senior Independent Director. Trudy also serves as Chair of Accsys Technologies PLC. Trudy will continue as a member of the Remuneration Committee and will chair the Nomination Committee. Christine Soden, Non-Executive Director, will be appointed as interim Senior Independent Director. Christine will continue in her current committee roles. Elementis also announced the appointment of Mike Humphrey as an Independent Non-Executive Director with effect from April 29, 2026. Mike Humphrey brings significant leadership and operational experience in the specialty chemicals sector, having been Chief Executive Officer of Croda International plc from 1999 to 2011, playing a crucial role in reshaping its strategic focus on specialty markets. During Mike's tenure, Croda developed into a focused, innovation-led business with strong margins, global reach and a premium market positioning. Announcement • Feb 25
Elementis plc Announces Retirement of Independent Non-Executive Director Dorothee Deuring and Changes in Committee Composition, Effective February 28, 2026 Elementis plc announces the following change to the Board of Directors: Having reached the ninth anniversary of her initial appointment to the Board of Elementis plc as an independent non-executive Director, Dorothee Deuring will be retiring from the Board and as a member of the Audit, Nomination and Remuneration Committees on 28 February 2026. Announcement • Nov 27
Elementis plc (LSE:ELM) acquired Alchemy Ingredients Limited for an enterprise value of £17 million. Elementis plc (LSE:ELM) acquired Alchemy Ingredients Limited for an enterprise value of £17 million on November 26, 2025. The enterprise value of £17 million is on a cash-free, debt-free basis and includes £1.5 million of contingent consideration.
Elementis plc (LSE:ELM) completed the acquisition of Alchemy Ingredients Limited on November 26, 2025. Announcement • Nov 12
Elementis plc to Report First Half, 2026 Results on Jul 30, 2026 Elementis plc announced that they will report first half, 2026 results on Jul 30, 2026 Announcement • Aug 02
Milberg, Krause & Kinsman File Class Action Lawsuit over Toxic Emissions in Kansas City The international plaintiffs' firm Milberg Coleman Bryson Phillips Grossman, PLLC ("Milberg"), in collaboration with the Krause & Kinsman Law Firm, has filed a federal class action lawsuit against Harcros Chemicals, Philips Electronics, Elementis PLC, and other entities for decades of toxic emissions that have harmed Kansas City residents. Filed in the U.S. District Court for the District of Kansas, the lawsuit alleges that the Harcros Chemicals plant and its predecessor companies have continuously released hazardous toxins, including the known human carcinogen ethylene oxide (EtO) and other dangerous chemicals, into surrounding residential neighborhoods since 1960. The complaint also identifies 11 schools located within the "toxic plume," where over 5,700 students have been consistently exposed to these harmful emissions. According to the lawsuit, these emissions have caused cancer, reproductive harm, and other severe health issues for Kansas residents. The Environmental Protection Agency (EPA) ranks the Harcros Kansas City facility among the most dangerous toxin emitters nationwide. Independent research shows that residents living near the facility, predominantly from Black and Hispanic communities, have a life expectancy up to 20 years shorter than those residing just a few miles further from the facility. Individuals who may be eligible to participate in the litigation include those who have lived, worked, or attended school within 2.5 miles of the Harcros facility and have experienced cancer or reproductive health issues. Announcement • Apr 29
Elementis plc to Report First Half, 2025 Results on Jul 31, 2025 Elementis plc announced that they will report first half, 2025 results on Jul 31, 2025 Announcement • Mar 26
Elementis plc, Annual General Meeting, Apr 29, 2025 Elementis plc, Annual General Meeting, Apr 29, 2025. Location: the offices of aando shearman llp, one bishops square, e1 6ad, london United Kingdom Announcement • Mar 06
Elementis plc Recommends Final Dividend Elementis plc recommended a final dividend of 2.9 cents per share (2023: 2.1 cents per share), resulting in a full-year dividend of 4.0 cents per share. Announcement • Jan 21
Elementis plc to Report Q4, 2024 Results on Mar 06, 2025 Elementis plc announced that they will report Q4, 2024 results on Mar 06, 2025 Announcement • Dec 24
Elementis plc Appoints Christopher Mills as Non-Executive Director with Effect from 1 January 2025 Elementis plc appointed Christopher Mills as a Non-Executive Director with effect from 1 January 2025. Mr. Mills founded Harwood Capital Management in 2011, a successor to its former parent company JO Hambro Capital Management, which he co-founded in 1993 and of which he was formerly the Chief Investment Officer. He is currently the Chief Executive Officer and Investment Manager of North Atlantic Smaller Companies Investment Trust plc, a UK listed investment trust, and a Non-Executive Director of several companies including Assetco plc, MJ Gleeson plc, PRS REIT plc and Oryx International Growth Fund Limited. Mr. Mills has indicated that he will donate his director fees received from the Company to the Harwood Charitable Trust, which provides educational support, mainly for doctors in Africa. Announcement • Nov 20
Elementis plc Announces Paul Waterman's Decision to Step Down as Chief Executive Officer Elementis plc announced that, following a period of discussion, Paul Waterman has agreed with the Board that it is the right time to transition the leadership of Elementis to a new Chief Executive Officer, following his nine years of service. Paul has agreed to remain with the Company until a successor is appointed, and will step down no later than the Company's Annual General Meeting in April 2025, remaining available as required for any transition or other support until the end of July 2025. The Board has initiated a process to identify and appoint a successor, and a further announcement in relation to this will be made in due course. Announcement • Jun 26
Gatemore Capital Management Sends Letter to Elementis PLC On June 25, 2024, Gatemore Capital Management LLP announced that it has sent a letter to Elementis PLC stating that the current management concerning capital allocation and operations, which have undermined investor confidence in the Company and resulted in a significant gap between Company's intrinsic value and its share price, it also proposed several actions to rectify Company's issues, urging the Board to take decisive steps to drive meaningful change, and Gatemore Capital stated that accelerating the cost-savings program, replacing the current CEO Paul Waterman, and conducting a strategic review including a potential disposal of the Talc business are essential to improving the Company's performance and unlocking shareholder value. Upcoming Dividend • Apr 26
Upcoming dividend of UK£0.017 per share Eligible shareholders must have bought the stock before 02 May 2024. Payment date: 31 May 2024. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (3.0%). Recent Insider Transactions • Apr 19
Group CEO & Executive Director recently sold UK£330k worth of stock On the 10th of April, Paul Waterman sold around 229k shares on-market at roughly UK£1.44 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Paul has been a net seller over the last 12 months, reducing personal holdings by UK£316k. Announcement • Mar 15
Elementis plc Appoints Heejae Chae as Non-Executive Director and Member of Audit, Nomination and Remuneration Committees, Effective from 25 March 2024 Elementis plc announced the appointment of Heejae Chae as a Non-Executive Director with effect from 25 March 2024. Heejae will join the Audit, Nomination and Remuneration Committees. Heejae is also a Non-Executive Director of IP Group plc, where he chairs the remuneration committee, and the Executive Chairman of Sys Group plc. He served as Chief Executive of Scapa Group plc, for twelve years, until its sale in 2021. Prior to joining Scapa Group plc, he held roles as Group Chief Executive of Volex Group plc, and was the Group General Manager, Radio Frequency Worldwide, for Amphenol Corporation. Heejae spent the early part of his career in finance at The Blackstone Group and Donaldson Lufkin and Jenrette, before moving into industry. Heejae holdsa Bachelor of Arts in Economics and Bachelor of Science in Engineering from Columbia University, and an MBA from Harvard University. Board Change • Mar 13
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Senior Independent Director Trudy Schoolenberg was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Mar 10
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 45% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Announcement • Mar 08
Elementis plc Proposes Dividend for the Year Ended 31 December 2023, Payable on 31 May 2024 Elementis plc announced that the Board has considered the strength of the balance sheet and the near-term prospects for the business and recommended the reinstatement of the ordinary dividend to an amount of 2.1 cents per share, which will be paid in pounds sterling. Dividend of 1.65 pence per share has been determined by converting the 2.1 cents into pounds sterling using the forward rate of £1.00:$1.2705, as determined on 28 March 2023. If approved at the AGM, the dividend will be paid on 31 May 2024 to shareholders included on the share register on 3 May 2024. Reported Earnings • Mar 07
Full year 2023 earnings released: EPS: US$0.048 (vs US$0.11 loss in FY 2022) Full year 2023 results: EPS: US$0.048 (up from US$0.11 loss in FY 2022). Revenue: US$713.4m (down 3.1% from FY 2022). Net income: US$28.2m (up US$90.8m from FY 2022). Profit margin: 4.0% (up from net loss in FY 2022). The move to profitability was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 3.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year. Announcement • Mar 07
Elementis plc Announces Directorate Changes Elementis plc announced the appointment of Maria Ciliberti as a Non-Executive Director with effect from 11 March 2024. Maria will join the Audit, Nomination and Remuneration Committees. Maria is President for the USA and Canada businesses at Royal Vopak, and has spent over 35 years in the petrochemical industry, having previously worked at The Dow Chemical Company, Columbia Gas of Ohio and Container Corporation of America in the USA. Maria has also spent over a decade in global leadership roles in Europe, with Celanese, GE Plastics (now part of SABIC) and Borealis. Maria holds a Bachelor of Science degree in Chemical Engineering and an MBA, both from The Ohio State University. Steve Good will retire from the Board at the conclusion of the Annual General Meeting on 30 April 2024 ("AGM"), as planned. Steve's responsibilities as chair of the Remuneration Committee will transfer to Clement Woon following the AGM. Announcement • Jan 26
KPS Capital Reportedly Said to Have Submitted Bid for Elementis KPS Capital Partners, LP recently explored a bid for UK specialty chemicals maker Elementis plc (LSE:ELM) but has since paused its work, two people familiar with the matter told Reuters. The New York-based private equity firm in December submitted an offer valuing the FTSE 250 company at about 160 pence per share, but the Elementis board wanted around 180 pence, one of the people said. Spokespeople for Elementis and KPS declined to comment. Announcement • Jan 25
Franklin Mutual Advisers Sends Letter to Elementis On January 25, 2024, Franklin Mutual Advisers LLC announced that it has sent 2nd letter to Elementis PLC board of directors, stating that it is writing to express its dismay at recent media reports that the Company has rejected a 160p takeover offer from KPS Capital Partners, in its view, this recent interest from KPS, coupled with prior offers from Minerals Technologies, and Innospec, again confirm mutual series' view that the Company is a desirable acquisition target, and it believes this indication of interest should be the catalyst to launch a formal process to maximize shareholder value. In addition, Franklin Mutual Advisers concerned that, the Board does not appear to be acting in the best interests of its shareholders, it believes that the leadership team at the Company is missing a valuable opportunity to maximize the value of the Company and urged the Company board to initiate a sales process immediately, and to engage with all potential buyers to maximize shareholder value. Announcement • Jan 18
Elementis plc to Report Second Half, 2023 Results on Mar 07, 2024 Elementis plc announced that they will report second half, 2023 results on Mar 07, 2024 Buying Opportunity • Jan 12
Now 20% undervalued Over the last 90 days, the stock is up 6.3%. The fair value is estimated to be UK£1.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.8% over the last 3 years. Earnings per share has declined by 9.4%. Buying Opportunity • Nov 15
Now 21% undervalued Over the last 90 days, the stock is up 13%. The fair value is estimated to be UK£1.62, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.8% over the last 3 years. Earnings per share has declined by 9.4%. Announcement • Sep 13
Elementis plc, Annual General Meeting, Sep 20, 2023 Elementis plc, Annual General Meeting, Sep 20, 2023. New Risk • Aug 28
New major risk - Revenue and earnings growth Earnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • Jul 28
First half 2023 earnings released: EPS: US$0.044 (vs US$0.031 in 1H 2022) First half 2023 results: EPS: US$0.044 (up from US$0.031 in 1H 2022). Revenue: US$363.8m (down 6.1% from 1H 2022). Net income: US$25.7m (up 44% from 1H 2022). Profit margin: 7.1% (up from 4.6% in 1H 2022). Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.0% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Reported Earnings • Mar 08
Full year 2022 earnings released: US$0.11 loss per share (vs US$0.004 profit in FY 2021) Full year 2022 results: US$0.11 loss per share (down from US$0.004 profit in FY 2021). Revenue: US$736.4m (down 16% from FY 2021). Net loss: US$62.6m (down US$65.1m from profit in FY 2021). Revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 1.3% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Announcement • Feb 01
Yildirim Holding A.S. acquired Chromium business of Elementis plc for $119 million. Yildirim Holding A.S. agreed to acquire Chromium business of Elementis plc for an enterprise value of USD 170 million on November 30, 2022. The transaction includes the transfer of environmental liabilities of $35 million and other liabilities of $8 million, with the total cash proceeds on completion expected to be around $119m before tax, after all transaction costs and subject to customary closing working capital adjustments. The majority of the Elementis group costs previously allocated to Chromium are expected to be phased out by the end of 2023. The transaction values the Chromium business at 7.3 times EBITDA. The Chromium business reported Sales of $171 million. The transaction is subject to US regulatory approval, which is expected before the end of Q1 2023. The deal is expected to complete during the first quarter of 2023. Evercore Inc. (NYSE:EVR) and JPMorgan Chase & Co. (NYSE:JPM) acted as financial advisor to Elementis plc in the transaction. Lazard Ltd acted as financial advisor to Yildirim Holding A.S. Kevin Richardson, Nick Cline, Joel Mack, Julia Hatcher, Joshua Marnitz, Bryce Kaufman, Jared Grimley, Sean Finn, Adam Kestenbaum, Jeffrey Anderson, Les Carnegie, Damara Chambers, Jason Cruise, Max Hauser and Peter Todaro of Latham & Watkins LLP represented Yildirim Group.
Yildirim Holding A.S. acquired Chromium business of Elementis plc for $119 million on November 30, 2022. Announcement • Jan 19
Elementis plc to Report Fiscal Year 2022 Results on Mar 07, 2023 Elementis plc announced that they will report fiscal year 2022 results on Mar 07, 2023 Buying Opportunity • Nov 17
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be UK£1.26, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Recent Insider Transactions • Oct 03
Group CEO & Executive Director recently bought UK£71k worth of stock On the 28th of September, Paul Waterman bought around 75k shares on-market at roughly UK£0.95 per share. This transaction amounted to 7.6% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Paul's only on-market trade for the last 12 months. Reported Earnings • Aug 03
First half 2022 earnings released: EPS: US$0.036 (vs US$0.048 in 1H 2021) First half 2022 results: EPS: US$0.036 (down from US$0.048 in 1H 2021). Revenue: US$478.3m (up 5.8% from 1H 2021). Net income: US$20.8m (down 25% from 1H 2021). Profit margin: 4.3% (down from 6.1% in 1H 2021). Over the next year, revenue is forecast to grow 3.8% compared to a 20% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 04
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: US$0.004 (up from US$0.12 loss in FY 2020). Revenue: US$880.1m (up 17% from FY 2020). Net income: US$2.50m (up US$69.5m from FY 2020). Profit margin: 0.3% (up from net loss in FY 2020). Revenue exceeded analyst estimates by 2.8%. Over the next year, revenue is forecast to grow 4.2% compared to a 10% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Sep 07
Senior Independent Director recently bought UK£101k worth of stock On the 2nd of September, John O'Higgins bought around 66k shares on-market at roughly UK£1.54 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought UK£246k more in shares than they have sold in the last 12 months. Executive Departure • Sep 01
Non-Executive Chairman Andrew Duff has left the company On the 1st of September, Andrew Duff's tenure as Non-Executive Chairman ended after 7.4 years in the role. As of June 2021, Andrew still personally held 133.50k shares (UK£203k worth at the time). Andrew is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 3.42 years. Reported Earnings • Jul 30
First half 2021 earnings released: EPS US$0.048 (vs US$0.088 loss in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: US$452.1m (up 17% from 1H 2020). Net income: US$27.6m (up US$78.5m from 1H 2020). Profit margin: 6.1% (up from net loss in 1H 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 12
Full year 2020 earnings released: US$0.12 loss per share (vs US$0.08 profit in FY 2019) The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: US$751.3m (down 14% from FY 2019). Net loss: US$67.0m (down 244% from profit in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Mar 26
Senior Independent Director recently bought UK£72k worth of stock On the 23rd of March, John O'Higgins bought around 60k shares on-market at roughly UK£1.20 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought UK£120k more in shares than they have sold in the last 12 months. Reported Earnings • Mar 25
Full year 2020 earnings released: US$0.12 loss per share (vs US$0.08 profit in FY 2019) The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: US$751.3m (down 14% from FY 2019). Net loss: US$67.0m (down 244% from profit in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Mar 06
New 90-day high: UK£1.32 The company is up 4.0% from its price of UK£1.27 on 04 December 2020. The British market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£1.04 per share. 
